Autologous bone marrow transplant uses the patient's own stem cells, collected before high-dose chemotherapy or radiation, to rebuild healthy bone marrow afterward. This approach is commonly used to treat certain blood cancers and allows for intensive treatment while reducing the risk of rejection since the patient's own cells are used.
Autologous transplant is recommended for patients with certain blood cancers such as multiple myeloma or lymphoma who are candidates for high-dose therapy, where their own healthy stem cells can be used to restore bone marrow function afterward.